Total | PJP | No PJP | P value | Prophylaxis | No prophylaxis | P value | |
---|---|---|---|---|---|---|---|
All patients | 21,587 | 48 (0.2%) | 21,539 (99.8%) | 1141 (5.3%) | 20,446 (94.7%) | ||
Age | 58.1 ± 17.4 | 58.5 ± 18.4 | 58.1 ± 17.4 | 0.85 | 52.8 ± 17.7 | 58.3 ± 17.3 | < 0.01 |
Male | 5822 (27.0%) | 16 (33.3%) | 5806 (27.0%) | 0.32 | 285 (25.0%) | 5537 (27.1%) | 0.12 |
Prophylaxis | 1141 (5.3%) | 0 | 1141 (5.3%) | 0.10 | – | – | – |
RA | 11,646 | 13 (0.1%) | 11,633 (99.9%) | 72 (0.6%) | 11,574 (99.4%) | ||
Age | 63.4 ± 15.8 | 68.3 ± 17.3 | 13.4 ± 15.8 | 0.27 | 63.7 ± 14.1 | 63.4 ± 15.8 | 0.89 |
Male | 2507 (21.5%) | 5 (38.5%) | 2502 (21.5%) | 0.14 | 17 (23.6%) | 2490 (21.5%) | 0.67 |
Prophylaxis | 72 (0.6%) | 0 | 72 (0.6%) | 0.78 | – | – | – |
SLE | 5460 | 22 (0.4%) | 5438 (99.6%) | 629 (11.5%) | 4831 (88.5%) | ||
Age | 48.8 ± 16.3 | 46.8 ± 14.2 | 48.8 ± 16.4 | 0.57 | 46.4 ± 16.6 | 49.1 ± 16.3 | < 0.01 |
Male | 551 (10.1%) | 7 (31.8%) | 544 (10.0%) | < 0.01 | 73 (116%) | 478 (9.9%) | 0.18 |
Prophylaxis | 629 (11.5%) | 0 | 629 (11.6%) | 0.09 | – | – | – |
SpA | 2918 | 0 | 2918 (100.0%) | 49 (1.7%) | 2869 (98.3%) | ||
Age | 51.8 ± 16.3 | – | 51.8 ± 16.3 | – | 60.0 ± 14.6 | 51.7 ± 16.3 | < 0.01 |
Male | 2229 (76.4%) | – | 2229 (76.4%) | – | 42 (85.7%) | 2187 (76.2%) | 0.12 |
Prophylaxis | 49 (1.7%) | – | 49 (1.7%) | – | – | – | – |
IMM | 1026 | 7 (0.7%) | 1019 (99.3%) | 220 (21.4%) | 806 (78.6%) | ||
Age | 61.8 ± 15.9 | 66.6 ± 14.6 | 61.8 ± 15.9 | 0.43 | 59.7 ± 13.3 | 62.4 ± 16.5 | 0.01 |
Male | 343 (33.4%) | 2 (28.6%) | 341 (33.5%) | 0.78 | 78 (35.5%) | 265 (32.9%) | 0.47 |
Prophylaxis | 220 (21.4%) | 0 | 220 (21.6%) | 0.17 | – | – | – |
AAV | 430 | 6 (1.4%) | 424 (98.6%) | 135 (31.4%) | 295 (68.6%) | ||
Age | 65.0 ± 17.8 | 64.0 ± 18.0 | 65.0 ± 17.8 | 0.89 | 63.7 ± 18.4 | 65.6 ± 17.5 | 0.30 |
Male | 177 (41.2%) | 2 (33.3%) | 175 (41.3%) | 0.70 | 67 (49.6%) | 110 (37.3%) | 0.02 |
Prophylaxis | 135 (31.4%) | 0 | 135 (31.8%) | 0.10 | – | – | – |
SSc | 109 | 2 (1.8%) | 107 (98.2%) | 36 (33.0%) | 73 (67.0%) | ||
Age | 54.4 ± 15.9 | 79.0 ± 14.1 | 54.0 ± 15.6 | 0.03 | 52.5 ± 18.5 | 55.4 ± 14.4 | 0.37 |
Male | 15 (13.8%) | 0 | 15 (14.0%) | 0.57 | 8 (22.2%) | 7 (9.6%) | 0.07 |
Prophylaxis | 36 (33.0%) | 0 | 36 (33.6%) | 0.32 |